Tissue engineering via local gene delivery: update and future prospects for enhancing the technology

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Gene Therapy

Background:

• Local gene transfer is crucial for tissue regeneration.
• Gene activated matrix (GAM) is a plasmid-based technology for localized gene delivery.
• Previous research has explored GAM's potential in various tissue engineering applications.

Purpose of the Study:

• To review the current status of gene activated matrix (GAM) technology.
• To evaluate GAM's efficacy as a platform for local gene delivery in diverse tissues.
• To discuss advancements enhancing GAM's potential in tissue engineering.

Main Methods:

• Review of studies published over the past 6 years on GAM technology.
• Analysis of GAM's capacity for plasmid DNA delivery to injured tissues (tendon, ligament, bone, muscle, skin, nerve).
• Assessment of in vivo gene transfer outcomes in bone, skin, and nerve regeneration models.

Main Results:

• GAM facilitates plasmid gene delivery to acutely injured tendon, ligament, bone, muscle, skin, and nerve.
• Direct in vivo gene transfer using GAM in bone, skin, and nerve resulted in significant regenerative responses compared to controls.
• New technologies are emerging to improve local gene delivery with GAM.

Conclusions:

• Gene activated matrix (GAM) shows promise as a versatile platform for local gene delivery and tissue regeneration.
• GAM technology has demonstrated efficacy in promoting healing across multiple tissue types.
• Ongoing technological advancements are expected to further enhance GAM's application in tissue engineering, balancing risk and benefit.